Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Commission File Number 001-39729 SOTERA HEALTH COMPANY FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to (Exact name of registrant as specified in its charter) | Delaware | | 47-3531161 | ...

Sotera Health Company (SHC) reported $254.52 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 2.6%. EPS of $0.14 for the same period compares to $0.13 a year ago.The reported revenue represents a surprise of +3.63% over the Zacks Consensus Estimate of $245.61 million. With the consensus EPS estimate being $0.12, the EPS surprise was +16.67%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to ...

Core Viewpoint - Sotera Health Company reported quarterly earnings of $0.14 per share, exceeding the Zacks Consensus Estimate of $0.12 per share, and showing a slight increase from $0.13 per share a year ago, indicating a 16.67% earnings surprise [1][2] Financial Performance - The company posted revenues of $254.52 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.63%, compared to $248.18 million in the same quarter last year [2] - Over the last four quarters, Sotera Health has exceeded consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - Sotera Health shares have declined approximately 15.9% since the beginning of the year, while the S&P 500 has decreased by 5.3% [3] - The current Zacks Rank for Sotera Health is 3 (Hold), indicating expected performance in line with the market in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is $0.19 on revenues of $283.2 million, and for the current fiscal year, it is $0.75 on revenues of $1.13 billion [7] - The outlook for the Medical Services industry, where Sotera Health operates, is currently in the top 28% of over 250 Zacks industries, suggesting a favorable environment for stock performance [8]

Sotera Health Company (SHC) Q1 2025 Earnings Call May 01, 2025 09:00 AM ET Speaker0 Please also note that this event is being recorded. I would now like to turn the conference over to Vice President of Investor Relations and Treasurer, Jason Peterson. Jason, I turn the call over to you. Speaker1 Good morning and thank you. Welcome to Sotera Health's first quarter twenty twenty five earnings call. You can find today's press release and accompanying supplemental slides on the Investors section of our website ...

May 1, 2025 © 2025 Sotera Health Company | All Rights Reserved. Safeguarding Global Health® First-Quarter 2025 Earnings Results Cautionary Note Regarding Forward-Looking Statements and Non-GAAP Financial Measures Unless expressly indicated or the context requires otherwise, the terms "Sotera Health," "Company," "we," "us," and "our" in this document refer to Sotera Health Company, a Delaware corporation, and, where appropriate, its subsidiaries on a consolidated basis. This release contains forward- looking ...

CLEVELAND, OH, May 1, 2025 – Sotera Health Company ("Sotera Health" or the "Company") (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three months ended March 31, 2025. First-quarter 2025 net revenues increased 2.6% to $255 million, compared to $248 million in the first-quarter 2024. Net revenues increased 4.4% on a constant currency basis. Net loss was $1 ...

Q1 2025 net revenues increased 2.6% to $255 million, compared to Q1 2024, or 4.4% on a constant currency basisQ1 2025 net loss of $13 million or $0.05 per diluted share, compared to net income of $6 million or $0.02 per diluted share in Q1 2024Q1 2025 Adjusted EBITDA(1) increased 8.8% to $122 million, compared to Q1 2024, or 11.2% on a constant currency basisQ1 2025 Adjusted EPS(1) of $0.14, an increase of $0.01 per diluted share, compared to Adjusted EPS of $0.13 in Q1 2024Company reaffirms full-year 2025 ...

CLEVELAND, April 17, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced it will release its financial results for the first-quarter ended March 31, 2025 before the market opens on Thursday, May 1, 2025. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company’s financial re ...

Investors in Sotera Health Company (SHC) need to pay close attention to the stock based on moves in the options market lately. That is because the May 16, 2025 $10.00 Call had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could ...

We add real-time buy and sell signals on these, as well as other trading opportunities which we provide in our active chat community. We look at companies with a defensible competitive advantage and the opportunity and/or business models which have the potential to generate considerable operational leverage.If you are interested in similarly small, high-growth potential stocks you could join us at our marketplace service SHU Growth Portfolio , where we maintain a portfolio and a watchlist of similar stocks. ...